You are here

Vaccines

Primary tabs

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Members

Kathy Gilbeaux mdmcdonald MDMcDonald_me_com mike kraft

Email address for group

vaccines_global@m.resiliencesystem.org

Why Poorer Countries Aren't Likely To Get The Pfizer Vaccine Any Time Soon

This week, the world heard encouraging news about a vaccine for COVID-19.

On Monday, the pharmaceutical company Pfizer, and its partner BioNTech, said their experimental vaccine appears to work – and work quite well. A preliminary analysis suggests the vaccine is more than 90 percent effective at preventing COVID-19 symptoms.

Health officials hope to start vaccinating some Americans in a few months.

"The vaccine is on its way, folks," Dr. Anthony Fauci told a crowd Tuesday, via video link, outside Brooklyn Borough Hall.

But what about the rest of world, especially people in poorer counties. Is the vaccine "on its way for them?"

Problem, Solution, SitRep, or ?: 

Brazil Halts Chinese Vaccine Trial, Critics See Politics

Brazil halted a late-stage trial of a Chinese vaccine on Monday that had been considered a global front-runner in the race to develop a protective shot for the coronavirus after a “serious adverse” reaction in a participant.

The decision provoked a political firestorm on Tuesday after President Jair Bolsonaro, who has been critical of China and spoken dismissively of its vaccine, CoronaVac, called the suspension a political victory.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pfizer says early data signals COVID-19 vaccine is effective

 

Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

AstraZeneca says COVID-19 vaccine could arrive in January of next year

 

A long-awaited coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca, which is developing a treatment.

The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., the U.K. and other countries to determine its safety and effectiveness. Once those results are reported, regulators will have to approve the vaccine for widespread use.

AstraZeneca said it will analyze data from its vaccine trials in November and December. If the results look promising, it will move quickly to ramp up manufacturing and obtain government approval in the U.S. and elsewhere, Chief Executive Pascal Soriot said Thursday.

Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.849 seconds.